| Literature DB >> 35665244 |
Yi Chang1, Xiangyang Qian1, Hongwei Guo1, Yizhen Wei1, Cuntao Yu1, Xiaogang Sun1, Bo Wei1, Qiong Ma1, Yi Shi1.
Abstract
Background: To compare outcomes between sinus replacement (SR) and conservative repair (CR) for dissected roots with normal size.Entities:
Keywords: aortic dissection; aortic root repair; propensity score matching; prospective cohort study; sinus replacement
Year: 2022 PMID: 35665244 PMCID: PMC9160325 DOI: 10.3389/fcvm.2022.880411
Source DB: PubMed Journal: Front Cardiovasc Med ISSN: 2297-055X
Figure 1The technical details of sinus replacement. (A) Showed deeply dissected non-coronary sinus. (B) Showed the intimal flap removed. (C) Showed the scallop-shaped patch sewed with remanent intima and adventitia together.
Figure 2The technical details of sinus replacement. (A) Showed the intima of coronary orifice trimmed into button. (B) Showed the intimal button attached snugly to the adventitia. (C) Showed the patch and the re-implanted button.
Baseline characteristics.
|
|
|
|
|
| ||||
|---|---|---|---|---|---|---|---|---|
|
|
|
|
|
|
| |||
| Age, year (X ±SD) | 52.3 ± 11.5 | 51.6 ±11.0 | 52.9 ± 11.9 | 0.27 | 53.2 ± 11.2 | 53.2 ± 10.9 | 53.2 ±11.6 | 0.98 |
| BMI (X ±SD) | 26.6 ±4.3 | 26.7 ±4.7 | 26.5 ± 3.9 | 0.80 | 26.3 ± 4.4 | 26.3 ± 4.9 | 26.4 ± 3.8 | |
| Male ( | 263(68.0) | 130(69.5) | 133(66.5) | 0.53 | 194(68.3) | 97(68.3) | 97(68.3) | 1.00 |
| HT ( | 325(84.0) | 150(80.2) | 175(87.5) | 0.05 | 239(84.2) | 113(79.6) | 126(88.7) | 0.05 |
| CAD ( | 60(15.5) | 23(12.3) | 37(18.5) | 0.09 | 37(13.0) | 20(14.1) | 17(12.0) | 0.72 |
| DM ( | 12(3.1) | 5(2.7) | 7(3.5) | 0.64 | 10(3.5) | 3(2.1) | 7(4.9) | 0.34 |
| COPD ( | 3(0.8) | 2(1.1) | 1(0.5) | 0.61* | 3(1.1) | 2(1.4) | 1(0.7) | 1.00 |
| CRI ( | 9(2.3) | 3(1.6) | 6(3.0) | 0.51* | 7(2.5) | 3(2.1) | 4(2.8) | 1.00 |
| Previous heart surgery ( | 3(0.8) | 1(0.5) | 2(1.0) | 0.22* | 3(2.1) | 1(0.7) | 2(1.4) | 0.22 |
| VMS ( | 3(0.8) | 3(1.6) | 0(0.0) | 0.11* | 0(0.0) | 0(0.0) | 0(0.0) | NA |
| Initial tear ( | 0.05 | 0.98 | ||||||
| aAO | 289(74.7) | 133(71.1) | 156(78.0) | 220(77.5) | 110(77.5) | 110(77.5) | ||
| Arch | 85(22.0) | 50(26.7) | 35(17.5) | 57(20.1) | 28(19.7) | 29(20.4) | ||
| DTA | 13(3.4) | 4(2.1) | 9(4.5) | 7(2.5) | 4(2.8%) | 3(2.1) | ||
| Type of CAI (left) ( | 0.04* | 1.00 | ||||||
| No | 361(93.3) | 169(90.4) | 192(96.0) | 270(95.1) | 136(95.8) | 134(94.4) | ||
| A | 26(6.7) | 18(9.6) | 8(4.0) | 14(4.9) | 6(4.2) | 8(5.6) | ||
| B | 0(0.0) | 0(0.0) | 0(0.0) | 0(0.0) | 0(0.0) | 0(0.0) | ||
| C | 0(0.0) | 0(0.0) | 0(0.0) | 0(0.0) | 0(0.0) | 0(0.0) | ||
| Type of CAI (right) ( | 0.01* | 0.86 | ||||||
| No | 265(68.5) | 116(62.0) | 149(74.5) | 202(71.1) | 97(68.3) | 105(73.9) | ||
| A | 98(25.3) | 60(32.1) | 38(19.0) | 65(22.9) | 35(24.6) | 30(1.1) | ||
| B | 17(4.4) | 6(3.2) | 11(5.5) | 11(3.9) | 6(4.2) | 5(3.5) | ||
| C | 7(1.8) | 5(2.7) | 2(1.0) | 6(2.1) | 4(2.8) | 2(1.4) | ||
| Scr, μmol/L (X ±SD) | 96.4 ± 35.8 | 95.4 ± 37.3 | 97.4 ± 34.4 | 0.58 | 93.4 ± 31.5 | 89.5 ± 28.8 | 97.2 ± 33.7 | 0.03 |
| Lac,mmol/L (media | 1.47 (1.06–2.17) | 1.54 (1.14–2.20) | 1.41 (1.03–2.16) | 0.28§ | 1.43 (1.08–2.13) | 1.45 (1.14–2.17) | 1.38 (1.06–2.03) | 0.99§ |
| GPT, IU/L (media | 22.0 (15.0–36.0) | 23.0 (15.0–35.0) | 20.0 (14.0–36.0) | 0.40§ | 23.0 (14.0–36.0) | 22.0 (14.0–32.0) | 25.0 (14.0–37.0) | 0.72§ |
| TnI, ng/ml (X ±SD) | 0.05 ±0.19 | 0.05 ±0.11 | 0.05 ±0.24 | 0.84 | 0.05 ±0.16 | 0.05 ±0.11 | 0.04 ±0.20 | 0.58 |
| Root diameter, mm (X ±SD) | 37.5 ± 4.3 | 38.0 ± 4.3 | 37.1 ± 4.4 | 0.03 | 37.7 ± 4.5 | 38.0 ± 4.3 | 37.4 ± 4.6 | 0.09 |
| AR ( | 0.003* | 0.28 | ||||||
| No or trivial | 176(45.5) | 76(40.6) | 100(50.0) | 124(43.7) | 55(38.7) | 69(48.6) | ||
| Mild | 155(40.1) | 75(40.1) | 80(40.0) | 115(40.5) | 57(40.1) | 58(40.8) | ||
| Moderate | 39(10.1) | 28(15.0) | 11(5.5) | 31(10.9) | 23(16.2) | 8(5.6) | ||
| Moderate-severe | 12(3.1) | 8(4.3) | 4(2.0) | 10(3.5) | 7(4.9) | 3(2.1) | ||
| severe | 3(0.8) | 0(0.0) | 3(1.5) | 2(0.7) | 0(0.0) | 2(1.4) | ||
SR, sinus replacement; CR, conservative repair; HT, hypertension; CAD, coronary artery disease; DM, diabetes mellitus; CRI, chronic renal insufficiency; VMS, visceral malperfusion syndrome; aAO, ascending aorta; DTA, descending thoracic aorta; CAI, coronary artery involvement; Scr, serum creatinine; Lac, lactic acid; IQR, Interquartile Range; GPT, glutamic-pyruvic transaminase; TnI, troponin I; AR, aortic regurgitation.
*Fisher's exact test was used.
.
Perioperative outcome characteristics.
|
|
|
|
|
| ||||
|---|---|---|---|---|---|---|---|---|
|
|
|
|
|
|
| |||
| MV duration, hour (median, IQR) | 21.0 (13.0–44.0) | 21.0 (13.0–56.0) | 21.0 (13.0–41.5) | 0.34§ | 19.0 (13.0–40.0) | 20.0 (13.0–43.0) | 18.5 (13.0–40.0) | 0.59§ |
| ICU stay, day (X ±SD) | 5.4 ± 4.7 | 5.5 ± 5.1 | 5.3 ± 4.2 | 0.66 | 5.0 ± 4.3 | 5.0 ± 4.8 | 5.0 ± 3.7 | 0.97 |
| Operative mortality ( | 18(4.7) | 6(3.2) | 12(6.0) | 0.19 | 15(5.3) | 5(3.5) | 10(7.0) | 0.27 |
| Restarted CPB for root bleeding ( | 17(4.4) | 3(1.6) | 14(7.0) | 0.002 | 15(5.3) | 3(2.1) | 12(8.5) | 0.03 |
| PMI ( | 1(0.3) | 0(0.0) | 1(0.5) | 1.00* | 1(0.3) | 0(0.0%) | 1(0.7) | 1.00 |
| Reoperation for bleeding ( | 7(1.8) | 2(1.1) | 5(2.5) | 0.45* | 2 (0.7) | 0(0.0) | 2(1.4) | 0.50 |
| IABP ( | 1(0.3) | 0(0.0) | 1(0.5) | 1.00* | 1(0.4) | 0(0.0) | 1(0.7) | 1.00 |
| ECMO ( | 4(1.0) | 0(0.0) | 4(2.0) | 0.12* | 4(1.4) | 0(0.0) | 4(2.8) | 0.13 |
| Stroke ( | 8(2.1) | 1(0.5) | 7(3.5) | 0.07* | 5 (1.8) | 0(0.0) | 5(3.5) | 0.06 |
| CRRT ( | 23(5.9) | 12(6.4) | 11(5.5) | 0.70 | 14(4.9) | 7(4.9) | 7(4.9) | 1.00 |
| Paraplegia ( | 6(1.6) | 0(0.0) | 6(3.0) | 0.03* | 3(1.1) | 0(0.0) | 3(2.1) | 0.25 |
SR, sinus replacement; CR, conservative repair; MV, mechanical ventilation; IQR, Interquartile Range; ICU, intensive care unit; CPB, CABG, coronary artery bypass grafting; PMI, myocardial infarction; IABP, intra-aortic balloon pump implantation; ECMO, extracorporeal membrane oxygenation; CRRT, continuous renal replacement therapy.
*Fisher's exact test was used.
Operative characteristics.
|
|
|
|
|
| ||||
|---|---|---|---|---|---|---|---|---|
|
|
|
|
|
|
| |||
| SP ( | 187(48.3) | 187(100.0) | 0(0.0) | – | 142(50.0) | 142(100.0) | 0(0.0) | – |
| LCS | 17(9.1) | 17(9.1) | 0(0.0) | 13(4.6) | 13(9.2) | 0(0.0) | ||
| RCS | 53(28.3) | 53(28.3) | 0(0.0) | 36(12.7) | 36(25.4) | 0(0.0) | ||
| NCS | 123(65.8) | 123(65.8) | 0(0.0) | 92(32.4) | 92(64.8) | 0(0.0) | ||
| Commissure reattachment ( | 142(36.7) | 66(35.3) | 76(38.0) | 0.58 | 105(37.0) | 52(36.6) | 53(37.3) | 0.90 |
| Arch repair ( | 0.95* | 0.96 | ||||||
| None | 7(1.8) | 4(2.1) | 3(1.5) | 7(1.8) | 4(2.8) | 3(2.1) | ||
| HAR | 17(4.4) | 8(4.3) | 9(4.5) | 11(3.9) | 5(3.5) | 6(4.2) | ||
| TAR | 363(93.8) | 175(93.6) | 188(94.0) | 266(93.7) | 133(93.7) | 133(93.7) | ||
| DTA management ( | 0.08 | 0.60 | ||||||
| None | 48(12.4) | 20(10.7) | 28(14.0) | 38(13.4) | 16(11.3) | 22(15.5) | ||
| FET | 308(79.6) | 157(84.0) | 151(75.5) | 224(78.9) | 116(81.7) | 108(76.1) | ||
| Endovascular stent | 31(8.0) | 10(5.3) | 21(10.5) | 22(7.7) | 10(7.0) | 12(8.5) | ||
| CABG ( | 64(16.5) | 34(18.2) | 30(15.0) | 0.40 | 47(16.5) | 28(9.7) | 19(13.4) | 0.16 |
| CPB duration, min (X ±SD) | 183.5 ± 71.6 | 184.7 ± 61.9 | 182.5 ± 79.7 | 0.76 | 185.8 ± 74.0 | 185.7 ± 62.0 | 185.8 ± 84.6 | 0.99 |
| Cross-clamp duration, min (X ±SD) | 112.2 ± 41.9 | 114.7 ± 43.6 | 109.9 ± 40.3 | 0.26 | 113.1 ± 39.7 | 114.3 ± 39.9 | 112.0 ± 39.6 | 0.62 |
| HCA duration, min (X ±SD) | 14.0 ± 9.3 | 14.3 ± 8.8 | 13.7 ± 9.7 | 0.53 | 13.6 ± 9.3 | 13.9 ± 9.2 | 13.6 ± 9.4 | 0.94 |
| Operation duration, hour, (X ±SD) | 6.4 ± 1.9 | 6.3 ± 1.7 | 6.5 ± 2.0 | 0.20 | 6.4 ± 1.9 | 6.3 ± 1.7 | 6.4 ± 2.1 | 0.46 |
SR, sinus replacement; CR, conservative repair; LCS, left coronary sinus; RCS, right coronary sinus; NCS, none coronary sinus; HAR, hemi-arch replacement; TAR, total arch replacement; DTA, descending thoracic aorta; FET, frozen elephant trunk; CABG, coronary artery bypass grafting; CPB, cardiopulmonary bypass; HCA, hypothermic circulatory arrest.
*Fisher's exact test was used.
Figure 3Cumulative event rate of reoperation at 24 months of follow-up for subjects in different surgical groups. (A) Before matching. (B) After matching.
Figure 4Cumulative event rate of death at 24 months of follow-up for subjects in different surgical groups. (A) Before matching. (B) After matching.